Nuvalent, Inc. financial data

Symbol
NUVL on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1,430 % -32.4%
Debt-to-equity 10.4 % +90.4%
Return On Equity -39.47 % -37.9%
Return On Assets -35.75 % -31.7%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 2,600,000,000 USD +1.4%
Weighted Average Number of Shares Outstanding, Basic 72,143,466 shares +9.8%
Weighted Average Number of Shares Outstanding, Diluted 72,143,466 shares +9.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 308,597,000 USD +67.8%
General and Administrative Expense 89,781,000 USD +58.7%
Operating Income (Loss) -398,378,000 USD -65.6%
Nonoperating Income (Expense) 17,548,000 USD +4.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -380,830,000 USD -70.2%
Income Tax Expense (Benefit) 605,000 USD +2.3%
Net Income (Loss) Attributable to Parent -381,479,000 USD -70.1%
Earnings Per Share, Basic -5 USD/shares -53.7%
Earnings Per Share, Diluted -5 USD/shares -53.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 115,752,000 USD -68.7%
Marketable Securities, Current 827,351,000 USD +3.5%
Assets, Current 956,945,000 USD -18.9%
Other Assets, Noncurrent 22,965,000 USD +1.5%
Assets 979,910,000 USD -17.6%
Accounts Payable, Current 22,010,000 USD +38.1%
Employee-related Liabilities, Current 11,817,000 USD +73.1%
Accrued Liabilities, Current 48,795,000 USD +1.2%
Liabilities, Current 89,151,000 USD +74.4%
Other Liabilities, Noncurrent 140,000 USD
Liabilities 134,511,000 USD +98.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2,370,000 USD +72.6%
Retained Earnings (Accumulated Deficit) -853,724,000 USD -80.8%
Stockholders' Equity Attributable to Parent 845,399,000 USD -24.6%
Liabilities and Equity 979,910,000 USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -54,821,000 USD -51.9%
Net Cash Provided by (Used in) Financing Activities 4,548,000 USD -24%
Net Cash Provided by (Used in) Investing Activities 25,417,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -24,856,000 USD +89.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 115,752,000 USD -68.7%
Deferred Tax Assets, Valuation Allowance 220,000,000 USD +1.2%
Deferred Tax Assets, Gross 220,000,000 USD +1.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -380,438,000 USD -71.7%
Deferred Tax Assets, Operating Loss Carryforwards 56,677,000 USD +61.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 80,906,000 USD +55.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%